Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
Mario Stampanoni Bassi, Luana Gilio, Pierpaolo Maffei, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaça, Ronald S. Duman
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 310
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors
Hui Ma, Chenyang Li, Jinpeng Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 6
Open Access | Times Cited: 104
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor
Graziela Vieira, Juliana Cavalli, Elaine Cristina Dalazen Gonçalves, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 792-792
Open Access | Times Cited: 71
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Antonio Bruno, Ettore Dolcetti, Francesca Romana Rizzo, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 54
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
Raphael Rifkin‐Zybutz, Simon Erridge, Carl Holvey, et al.
Psychopharmacology (2023) Vol. 240, Iss. 8, pp. 1735-1745
Open Access | Times Cited: 19
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4764-4764
Open Access | Times Cited: 24
Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications
Travis T. Denton, Gregory T. Carter, Moses Goddard, et al.
Muscle & Nerve (2025)
Closed Access
Down and High: Reflections Regarding Depression and Cannabis
Catherine C. Langlois, Stéphane Potvin, Atul Khullar, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28
How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies
Jonasz Dragon, Ewa Obuchowicz
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4511-4536
Closed Access | Times Cited: 4
Chaperone Sigma1R and Antidepressant Effect
М. В. Воронин, Yulia V. Vakhitova, С. Б. Середенин
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7088-7088
Open Access | Times Cited: 30
Targeting the endocannabinoid system with microbial interventions to improve gut integrity
Jack Jansma, Fleur Brinkman, Saskia van Hemert, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110169-110169
Open Access | Times Cited: 29
Maternal separation: Does it hold the potential to model consequences of postpartum depression?
Annakarina Mundorf, Ibrahim Bölükbas, Nadja Freund
Developmental Psychobiology (2022) Vol. 64, Iss. 1
Open Access | Times Cited: 16
Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety
Wenjiao Yang, Xudong Gong, Haiguo Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116048-116048
Closed Access | Times Cited: 9
Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids and endocannabinoid system modulation
Catherine Healy, Georgina Gethin, Abhay Pandit, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115714-115714
Open Access | Times Cited: 8
The Endocannabinoid System May Modulate Sleep Disorders in Aging
Eric Murillo-Rodrı́guez, Henning Budde, André Barciela Veras, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 2, pp. 97-108
Open Access | Times Cited: 23
Additive anxiolytic-like effect of citicoline and ACPA in the non-acute restraint stress (NARS) and acute restraint stress (ARS) mice
Aysan Amnzade, Mohammad‐Reza Zarrindast, Fatemeh Khakpai
Physiology & Behavior (2024) Vol. 277, pp. 114506-114506
Closed Access | Times Cited: 2
Anandamide Modulates Thermal Avoidance in Caenorhabditis elegans Through Vanilloid and Cannabinoid Receptor Interplay
Marzieh Abdollahi, Jesús D. Castaño, Jennifer Ben Salem, et al.
Neurochemical Research (2024) Vol. 49, Iss. 9, pp. 2423-2439
Open Access | Times Cited: 2
Regulation of Calcium Oscillations in β-Cells by Co-activated Cannabinoid Receptors
Aurélien Laguerre, Kaya Keutler, Sebastian Hauke, et al.
Cell chemical biology (2020) Vol. 28, Iss. 1, pp. 88-96.e3
Open Access | Times Cited: 18
The Endocannabinoid System Contributes to Electroacupuncture Analgesia
Iona MacDonald, Yi‐Hung Chen
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 16
Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depression-like behaviour via cannabinoid system in sleep deprivation rats
Tiandong Wang, Kang Niu, Anni Fan, et al.
Behavioural Brain Research (2020) Vol. 384, pp. 112545-112545
Closed Access | Times Cited: 17
Cannabinoids Receptors in COVID-19: Perpetrators and Victims
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 34, pp. 3832-3845
Closed Access | Times Cited: 8
Effect of MCH1, a fatty-acid amide hydrolase inhibitor, on the depressive-like behavior and gene expression of endocannabinoid and dopaminergic-signaling system in the mouse nucleus accumbens
Carlos Medina Saldivar, Grace Violeta Espinoza Pardo, Luis F. Pacheco Otalora
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 1
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels
Mohaddeseh Ebrahimi-Ghiri, Fatemeh Khakpai, Mohammad‐Reza Zarrindast
Journal of Psychopharmacology (2020) Vol. 35, Iss. 7, pp. 875-884
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top